• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

NxStage Medical Inc.

Trump reveals plan to overhaul kidney disease care

July 11, 2019 By Brad Perriello

The Trump administration yesterday revealed its plan to overhaul the way kidney disease is treated in the U.S., looking to increase early detection and emphasize transplants and home hemodialysis instead of in-clinic treatment via executive order. Shares of dialysis providers DaVita Healthcare (NYSE:DVA) and Fresenius (NYSE:FMS) took a hit earlier this week on news of the changes. The executive […]

Filed Under: Dialysis, Featured, Wall Street Beat Tagged With: Baxter, DaVita Inc., Dept. of Health & Human Services (HHS), Fresenius, NxStage Medical Inc.

FTC grants final approval for Fresenius’s $2B buyout of NxStage

April 10, 2019 By Fink Densford

The U.S. Federal Trade Commission said yesterday that it granted a final order of approval to Fresenius Medical Care (NYSE:FMS; ETR:FRE) for its $2 billion acquisition of NxStage Medical. The approval came with a caveat that the companies divest their assets and rights to research, develop, manufacture, market and sell NxStage’s bloodline tubing sets intended for use […]

Filed Under: Business/Financial News, Dialysis, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Fresenius, NxStage Medical Inc.

Fresenius closes $2B NxStage buyout, settles FCPA case for $255m

February 26, 2019 By Brad Perriello

Fresenius Medical Care (NYSE:FMS; ETR:FRE) said today that it closed the $2 billion acquisition of NxStage Medical and settled self-reported violations of the U.S. Foreign Corrupt Practices Act for nearly $255 million. The $30-per-share deal for the Lawrence, Mass.-based home hemodialysis pioneer, first announced in August 2017, was initially slated to close by the end of that year. […]

Filed Under: Featured, Legal News, Mergers & Acquisitions, Wall Street Beat Tagged With: Fresenius, NxStage Medical Inc.

FTC gives the go ahead to Fresenius, NxStage merger

February 20, 2019 By Fink Densford

The U.S. Federal Trade Commission said yesterday that it cleared Fresenius (NYSE:FMS) in its $2 billion acquisition of NxStage Medical (NSDQ:NXTM). As part of the approval, NxStage will have to part ways with its bloodline tubing set business, offloading them to B. Braun, according to the regulatory agency. The vote to approve the merger was split, however, […]

Filed Under: Business/Financial News, Dialysis, Featured, Mergers & Acquisitions Tagged With: Fresenius, NxStage Medical Inc.

U.S. gov’t shutdown again delays closing for Fresenius-NxStage merger

January 29, 2019 By Fink Densford

Fresenius (NYSE:FMS) said today that an interruption to the FTC’s review of its merger with NxStage Medical (NSDQ:NXTM), caused by the partial U.S. government shutdown, has again delayed the end-date of the deal which has now been extended to August 6, 2019. The end-date is not hard-set, Fresenius said, and could occur on an earlier date if there have […]

Filed Under: Business/Financial News, Dialysis, Mergers & Acquisitions Tagged With: Fresenius, NxStage Medical Inc.

Fresenius still awaiting FTC approval for NxStage acquisition

December 31, 2018 By Fink Densford

Fresenius (NYSE:FMS) said last Friday that it is still in the process of seeking approval from the U.S. Federal Trade Commission for its $2 billion merger with NxStage Medical (NSDQ:NXTM). The tie-up, which was delayed by NxStage in October in light of the FTC investigation, has been in the works for nearly a year and a half, having […]

Filed Under: Business/Financial News, Dialysis, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Fresenius, NxStage Medical Inc.

NxStage Medical, Fresenius again delay $2B merger

October 31, 2018 By Brad Perriello

NxStage Medical (NSDQ:NXTM) yesterday once more delayed its pending $2 billion merger with Fresenius (NYSE:FMS) as the U.S. Federal Trade Commission continues to examine the deal. In July, the German renal care giant and Lawrence, Mass.-based NxStage extended the deal’s closing date by 90 days, from August 7 to Nov. 5, saying it still expected to close the deal this year. […]

Filed Under: Dialysis, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Anti-Trust, Fresenius, NxStage Medical Inc.

NxStage touts home hemodialysis study data

October 18, 2018 By Fink Densford

NxStage Medical (NSDQ:NXTM) today released data from a study comparing home hemodialysis to traditional treatment in a skilled nursing facility, touting a lower risk of death and cardiovascular hospitalization for those treated more often with home hemodialysis. Full results from the trial are slated to be presented at the American Society of Nephrology Kidney Week 2018 […]

Filed Under: Blood Management, Clinical Trials Tagged With: NxStage Medical Inc.

Fresenius extends deadline for $2B NxStage buyout, tops Q2 earnings forecast

July 31, 2018 By Brad Perriello

Fresenius (NYSE:FMS) said today that it’s extending the deadline to close the $2 billion buyout of NxStage Medical (NSDQ:NXTM) by 90 days and posted second-quarter earnings that beat the consensus forecast. The German dialysis giant said it moved the merger deadline from August 7 to Nov. 5, but still expects to close the deal this year. […]

Filed Under: Dialysis, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Fresenius, NxStage Medical Inc.

UPDATE: NxStage deals bloodlines biz to B Braun to mollify FTC in sale to Fresenius

July 10, 2018 By Fink Densford

UPDATE: Now includes information from NxStage indicating that the sale was part of the process to obtain FTC clearance for its sale to Fresenius. B. Braun said today it inked a deal to acquire the NxStage Medical‘s (NSDQ:NXTM) bloodlines business, which operates under the Medisystems moniker. Bethlehem, Penn.-based B. Braun did not release any details of the […]

Filed Under: Business/Financial News, Mergers & Acquisitions Tagged With: B. Braun, NxStage Medical Inc.

NxStage touts reduced technique failure in Nx2me home hemodialysis study

December 8, 2017 By Fink Densford

NxStage Medical (NSDQ:NXTM) today released the results from a study of its Nx2me connected health remote patient management system for patients using home hemodialysis, touting a 29% reduction in technique failure of conversion to in-center hemodialysis by 29%. Results from the study were published in the journal Hemodialysis International, the Lawrence, Mass.-based company said. Data came from […]

Filed Under: Blood Management, Clinical Trials, Patient Monitoring Tagged With: NxStage Medical Inc.

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 12
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS